力诺药包：股东拟减持不超3%公司股份

Core Viewpoint - The shareholders of Lino Pharmaceutical (301188) plan to reduce their holdings by up to 6.9787 million shares, representing 3% of the company's total equity [1] Shareholder Actions - Jinan Caijin Fuxing Weishi Equity Investment Fund Partnership (Limited Partnership) and its concerted party Ningbo Meishan Free Trade Port Area Fuxing Weiying Equity Investment Fund Partnership (Limited Partnership) will execute the share reduction through centralized bidding and block trading [1]